Net Income

With just days until Christmas, CINCOM unveils discounted wellness bundles. The move tests the market's appetite for last-minute practical gifts.

A major acquisition turned sour, a 25% stock crash, and now a class action lawsuit. Inside Perrigo's costly infant formula venture and what it means.

Emergency rooms see a spike in injuries from decorating, toys, and winter weather. Experts share crucial tips to keep your family safe this season.

Chile's state oil firm, ENAP, sees massive investor demand for its debt buyback, a move that strengthens its balance sheet for a major energy transition.

Fortune 500 giant ARKO Corp. plans to take its petroleum wholesale business public, a strategic split aimed at unlocking value and focusing growth.

The newly public logistics firm reports soaring H1 2025 profits and revenue, yet its stock price tells a different, more cautious story.

Mirum raises over a quarter-billion dollars to acquire Bluejay Therapeutics, targeting a high-potential liver disease drug and signaling major growth.

A landmark executive order to reschedule cannabis and create a Medicare CBD program could unleash a $30B market and redefine the economics of the industry.

Holiday spending pushed credit balances to a new high, but a sharp rise in delinquencies signals a K-shaped economy where many face a financial reckoning.

A landmark executive order reclassifying cannabis is set to unleash a wave of biopharma innovation, validating science-first firms like Avicanna.

The powerboat giant expands its share repurchase in a show of financial strength, betting on long-term recovery despite a soft recreational market.

Alvotech and Teva's settlement with Regeneron for an Eylea biosimilar paves the way for a 2026 launch, promising increased competition and lower costs.

A new settlement positions a cost-effective alternative to the blockbuster eye drug Eylea for a 2026 U.S. launch, signaling intense market disruption.

T'way Air launches aggressive year-end deals for Seoul and Jeju, sparking a price war among low-cost carriers on the popular Singapore-Korea travel route.

Denarius Metals solidifies its Zancudo gold-silver project in Colombia by filing a key technical report, validating a major resource update.

In a fierce biotech talent war, Senti Bio's new equity grant for a key hire signals a strategic push for its gene therapy pipeline amid market volatility.

The sustainable materials firm saw net income jump 60% after a planned shutdown created a record backlog, setting the stage for a strong Q3.

With a massive capital raise and rapid microreactor progress, NANO Nuclear is positioning itself to power the AI boom and lead a new nuclear renaissance.

WhiteFiber lands a 10-year, 40 MW anchor deal with AI provider Nscale, validating its high-density strategy and fueling North Carolina's tech boom.

As Applied Digital preps its Q2 results, investors watch to see if its multi-billion dollar contracts can quell market volatility and affirm its AI future.